Deferasirox-defrijet (100 mg & 400 mg)

Sun Pharmaceutical Industries Ltd.

“Deferasirox” is the Drug / Molecule content in “Defrijet”. Deferasirox is mainly used to reduce chronic ieon overload in patients who are receiving long-term blood transfusions for conditions such as beta-thalassemia and other chronic anemia’s.

Indication

Defrijet is used in the treatment of chronic iron overload in transfusional hemosiderosis.

Note

Precaution

  • Defrijet is a prescription drug and should be used under proper medical guidance and advice.
  • Monitor renal function and CBC before starting the medication and regularly during the treatment.